AstraZeneca working with Oracle to use AI and real-world data to identify eligible patients for clinical trials and monitor safety signals
On Oct. 20, 2026, AstraZeneca announced that it is working with Oracle to use AI and real-world data…
-
-
Artificial Intelligence | Biotechnology | Clinical Research | Diagnostics | Genomics | Medical Device | Pharmaceutical | Therapeutics
OpenAI acquires Orchestra Bio Platform
On Oct. 20, 2026, OpenAI announced it has acquired Orchestra Bio, a platform that helps biopharma teams coordinate…
-
Merck to Acquire Silence Therapeutics for $1.3 Billion, Strengthening Rare Disease Platform
On Oct. 19, 2026, Merck announced it it has entered into a definitive agreement to acquire Silence Therapeutics,…
-
US prize-winning cancer scientist Wan Fengyi joins China’s Zhejiang University
On Oct. 19, 2026, a Johns Hopkins University scientist whose award-winning work suggests that a brief stomach bug…
-
Agriculture | Artificial Intelligence | Biotechnology | CRISPR | Genomics | Imaging | Implants | Infectious Disease | Nanotechnology | Neurology | Non-Profit Research | Quantum | Rare Disease | Stem Cell | Vaccine | Women's Health
researchers leaving the U.S. because of funding cuts and politicization of science
On Oct. 19, 2026, the Associated Press has reported that when the Trump administration began upending U.S. scientific…
-
Linda T. and John A. Mellowes Donate $50 Million to the Medical College of Wisconsin to Advance Precision Medicine
On Oct. 19, 2026, The Medical College of Wisconsin (MCW) announced a historic $50 million gift from Linda…
-
China’s Hansoh Pharma strikes drug deal with Roche worth over $15 billion
On Oct. 19, 2026, China’s Hansoh Pharmaceutical reported it has entered into a partnership and licensing deal with…
-
Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
On Oct. 16, 2026, Viatris announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI® (phentolamine…
-
New ways to catch a thief—via intruders’ airborne Environmental DNA
On Oct. 15, 2026, an international study, led by Norwegian experts at Oslo University Hospital with collaborators at…
-
Biotechnology | Cardiology | Disease | Genomics | Neurology | NIH | Oncology
Large-scale study advances detection of DNA mutations across the human genome
On Oct. 15, 2026, researchers in a Mayo Clinic-led study have shown how to detect a broad range…
-
China is a beacon of global embryo research, says scientist on return from US to lead lab
On Oct. 15, 2026, the South China Morning Post reported that leading life scientist Wu Jun, who recently…
-
Whitehouse advances plan for peptide drugs
On Oct. 15, 2026, the Food and Drug Administration (FDA) this week submitted a peptide “interim access policy”…
-
SimBioSys Secures FDA Clearance for TumorSight® Risk, Introducing the World’s First AI-Powered, MRI-Derived Breast Cancer Risk Assessment
On Oct. 15, 2026, SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and treated, today…
-
Senator Warnock Secures Nearly $100M in Federal Funding for HBCU STEM Programs
On Oct. 14, 2026, Senator Reverend Raphael Warnock (D-GA) announced a $97.1 million award in federal funding through…
-
RFK Jr’s anti-vaccine views influenced decision to shelve U.S. bird flu response plan
On Oct. 14, 2026, Health Secretary Robert F. Kennedy Jr.’s vaccine skeptical views influenced the decision to shelve…
-
Artificial Intelligence | Biotechnology | Non-Profit Research | Rare Disease | Therapeutics | Vaccine | Women's Health
As White House shifts focus toward AI and tech, U.S. science leaders defend role of the American university
On Oct. 14, 2026, this fall, the Massachusetts Institute of Technology, where 95% of students are STEM majors,…
-
Biotechnology | CRISPR | Diagnostics | Neurology | NIH | Oncology
Children’s Hospital of Philadelphia Researchers Identify Role of Newly Discovered Genetic Variant in Neurodevelopmental Disorder
On Oct. 13, 2026, Researchers from Children’s Hospital of Philadelphia (CHOP) have discovered the mechanisms of previously unknown…
-
Greenland Polar Bears Test Postive for H5N1 avian flu antibodies
On Oct. 13, 2026, an University of Inland Norway-led team reported that highly pathogenic avian influenza (HPAI) is…
-
Biotechnology | CRISPR | Diagnostics | HIV
Rice scientists engineer new tool to improve detection of HIV and other viruses
On Oct. 13, 2026, researchers at Rice University have developed an improved version of Cas13a that could make…
-
NASA’s SpaceX CRS-35 Mission to Launch Health Research
On Oct. 12, 2026, the National Aeronautics and Space Administration (NASA) announced that experiments focused on human and…
-
Artificial Intelligence | Biotechnology | Cardiology | Diagnostics | Genomics | Medicine | Neurology | NIH | Oncology | Telemedicine
Georgia Tech Opens Super Computer to researchers nationwide
On Oct. 12, 2026, Georgia Tech announced it is opening a new frontier in scientific computing with Nexus,…
-
GSK to Invest Over $800 Million to Expand Operations in Pennsylvania, Creating Over 300 New Jobs
On Oct. 9, 2026, the Pennsylvania Governor’s Office announced the Commonwealth has secured an over $800 million investment…
-
Tonix Pharmaceuticals breaks ground on Montana manufacturing facility
On Oct. 9, 2026, current and former local and statewide officials joined staff from the pharmaceuticals company Tonix…
-
Researchers Transform Old Blood Cells into Young Brain Cells
On Oct. 9, 2026, researchers from the University Hospital of Bonn and the University of Bonn have succeeded…
-
Teva Announces U.S, FDA Approval of WELTRUZA™ (Olanzapine) as the First and Only Once-Monthly Injectable for Adults with Schizophrenia
On Oct. 9, 2026, Teva Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved WELTRUZA™ (olanzapine)…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves Drug to Treat Lesions Caused by Herpes Simplex Virus
On Oct. 9, 2026, the U.S. Food and Drug Administration (FDA) has approved Asahi Kasei Therapeutics’ Hovilpri (pritelivir)…
-
Viatris Agrees to Acquire Pacira BioSciences for $1.65 billion in Cash, Becoming a Leader in Non-Opioid Pain Therapies
On Oct. 8, 2026, Viatris, a global healthcare company, and Pacira BioSciences, a leader in innovative non-opioid pain…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine
Washington confirms first detection of avian influenza in dairy cattle
On Oct. 8, 2026, the U.S. Department of Agriculture (USDA) National Veterinary Services Laboratory (NVSL) confirmed the first…
-
Biotechnology | CRISPR | Disease | Genomics
New technique holds promise for improved gene editing
On Oct. 7, 2026, a new study describes how scientists fused together components in bacteria that do not…
-
International, cross-sector collaboration commits nearly $2 billion to build foundational data for AI models to predict and treat disease
On Oct. 7, 2026, Biohub, the U.S. Department of Energy, the National Institutes of Health, and new funding…
